NEW YORK (GenomeWeb News) – Enigma Diagnostics has licensed two patents from Roche Molecular Systems for use in decentralized and point-of-care human and veterinary in vitro molecular diagnostics.

Enigma has licensed the rights to practice HybProbe real-time PCR chemistry and melt analysis and commercialize HybProbe PCR tests worldwide, Porton Down, England-based Enigma said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.